🧬 Genetic Disorder

Dubowitz Syndrome

Also known as: Facio-oculo-acousticorenal syndrome, Dubowitz-like syndrome

Dubowitz syndrome is a rare genetic disorder characterized by growth retardation, microcephaly, distinctive facial features, eczema, and mild to moderate intellectual disability. The severity of symptoms can vary widely among affected individuals. There is an increased risk of certain cancers, particularly leukemia and lymphoma.

ICD-10: Q87.8 Orphanet: 235 OMIM: 223370
👥 Less than 1 in 1,000,000 Prevalence

Dubowitz syndrome is a rare condition where kids grow slowly, have small heads, unique faces, skin problems like eczema, and may have trouble learning. They might also get sick more easily. Doctors help them with therapies and medicines to live healthier lives.

Signs & Symptoms

  • Growth retardation (prenatal and postnatal)
  • Microcephaly
  • Distinctive facial features (high forehead, sparse hair, blepharophimosis, ptosis, broad or unusual nasal bridge, small chin)
  • Eczema
  • Mild to moderate intellectual disability
  • Behavioral problems (hyperactivity, impulsivity)
  • Skeletal abnormalities (clinodactyly, syndactyly)
  • Speech delay
  • Increased risk of malignancy (leukemia, lymphoma)

Treatment Options

MEDICATION FDA Approved

Growth hormone therapy

MODERATELY EFFECTIVE
THERAPY

Special education and therapies (speech, occupational, physical)

SUPPORTIVE
MEDICATION FDA Approved

Eczema management (topical corticosteroids, emollients)

MODERATELY EFFECTIVE
THERAPY

Behavioral therapy

SUPPORTIVE
SURGERY

Surgical correction of skeletal abnormalities

MODERATELY EFFECTIVE
MEDICATION FDA Approved

Cancer treatment (chemotherapy, radiation, stem cell transplant)

MODERATELY EFFECTIVE

Diagnosis

  • Clinical evaluation based on characteristic features
  • Physical examination
  • Developmental assessment
  • Genetic testing (exome sequencing, candidate gene analysis) to identify causative mutations, although a specific gene has not been definitively identified in all cases.
  • Radiological studies (skeletal surveys)
  • Chromosome analysis (to rule out other chromosomal abnormalities)

History

Dubowitz syndrome was first described by Stanley Dubowitz in 1965, who reported on three unrelated children with similar clinical features. The etiology remained unknown, and diagnosis was based on clinical findings. Over the years, numerous case reports have expanded the understanding of the syndrome's phenotypic variability and associated complications.

Recent Breakthroughs

2022

Advancements in Exome Sequencing for Dubowitz Syndrome

While a definitive causative gene remains elusive for all cases, advancements in exome sequencing have aided in identifying potential candidate genes and excluding other genetic disorders with overlapping features. This has improved diagnostic accuracy and genetic counseling.

2023

Improved Cancer Surveillance Protocols for Dubowitz Syndrome

Due to the increased risk of malignancy, updated surveillance protocols have been developed to facilitate early detection and intervention, improving outcomes for affected individuals.